|
[15]
|
DCLSG/POG
|
10
|
5
|
Treatment N/S
|
|
6 died of leukemia
|
|
1 died of leukemia and infection
|
|
1 died of infection
|
|
1 died of treatment related toxicity
|
|
1 alive, 22 months after BMT in CR1
|
|
[13]
|
CCG
|
2
|
2
|
1 relapsed in bone marrow with bilateral chloromas on the hips. Treated with radiation and BMT, but later died due to disease
|
|
1 relapsed twice, treated with BMT, alive after 2 years
|
|
[6]
|
DCOG
|
6
|
N/S
|
Treatment N/S
|
|
Median EFS: 9 months
|
|
3-year EFS: 0 %
|
|
3-year OS: 0 %
|
|
[19]
|
Japan
|
1
|
N/S
|
Alive after 5 years, treated with chemotherapy only
|
|
[16]
|
Korea
|
3
|
N/S
|
1 received cord blood transplantation at 11 months, relapsed 4 months later, then died at 16 months
|
|
1 died during induction chemotherapy from multiple organ failure
|
|
1 achieved remission, but relapsed at 10 months, and died at 16 months
|
|
[56]
|
COG
|
8
|
N/S
|
Treatment N/S
|
|
3-year EFS: 14 %
|
|
3-year OS: 28 %
|
|
2 of 7 evaluable patients are alive (1 after chemotherapy, 1 after BMT) (personal communication)
|
